Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation

Noelle L. Cutter; Mena Yacoub; Robert D. Lucito; Nevenka Dimitrova; Elena Lum; Michael Vigliotti; Kazimierz Wrzeszczynski; Douglas A. Levine

doi:10.1158/1078-0432.OVCA13-A24

Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation

Noelle L. Cutter, Mena Yacoub, Robert D. Lucito, Nevenka Dimitrova, Elena Lum, Michael Vigliotti, Kazimierz Wrzeszczynski, Douglas A. Levine

Biology, Chemistry, Environmental Studies

Research & Scholarship: Contribution to conference › Abstract › peer-review

Original language	American English
DOIs	https://doi.org/10.1158/1078-0432.OVCA13-A24
State	Published - Oct 1 2013

Disciplines

Genetics
Biology
Oncology
Immunology and Infectious Disease

Access to Document

10.1158/1078-0432.OVCA13-A24License: Unspecified

Cite this

@conference{5c63b9d9f5634d6faf409b5c2eee5296,

title = "Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation",

author = "Cutter, {Noelle L.} and Mena Yacoub and Lucito, {Robert D.} and Nevenka Dimitrova and Elena Lum and Michael Vigliotti and Kazimierz Wrzeszczynski and Levine, {Douglas A.}",

note = "Ovarian cancers are highly heterogeneous and while chemotherapy is the preferred treatment many patients are intrinsically resistant or quickly develop resistance. Furthermore, all tumors that recur ultimately become resistant. Recent evidence suggests that epigenetic deregulation may be a key factor in the onset and maintenance of chemoresistance.",

year = "2013",

month = oct,

day = "1",

doi = "10.1158/1078-0432.OVCA13-A24",

language = "American English",

}

TY - CONF

T1 - Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation

AU - Cutter, Noelle L.

AU - Yacoub, Mena

AU - Lucito, Robert D.

AU - Dimitrova, Nevenka

AU - Lum, Elena

AU - Vigliotti, Michael

AU - Wrzeszczynski, Kazimierz

AU - Levine, Douglas A.

N1 - Ovarian cancers are highly heterogeneous and while chemotherapy is the preferred treatment many patients are intrinsically resistant or quickly develop resistance. Furthermore, all tumors that recur ultimately become resistant. Recent evidence suggests that epigenetic deregulation may be a key factor in the onset and maintenance of chemoresistance.

PY - 2013/10/1

Y1 - 2013/10/1

U2 - 10.1158/1078-0432.OVCA13-A24

DO - 10.1158/1078-0432.OVCA13-A24

M3 - Abstract

ER -